Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage
-
Published:1983-06
Issue:3
Volume:2
Page:253-259
-
ISSN:0722-2211
-
Container-title:European Journal of Clinical Microbiology
-
language:en
-
Short-container-title:Eur. J. Clin. Microbiol.
Author:
Eandi M.,Viano I.,Di Nola F.,Leone L.,Genazzani E.
Publisher
Springer Science and Business Media LLC
Subject
Microbiology (medical),Microbiology,Infectious Diseases,Microbiology (medical),General Medicine
Reference16 articles.
1. Gadebusch, H. H., Koupal, L. R., Celozzi, E., Shungu, D. L., Bland, J., Weissberger, B., Pelak, B. A., Fisch, E., Chung, S. K., Huber, J.: Norfloxacin (MK-366, AM-715), a new orally absorbed synthetic compound for the treatment of bacterial infections. In: Periti, P., Gialdroni Grassi, G.: Current Chemotherapy, Volume 1, American Society for Microbiology, Washington, DC, 1982, p. 351–353. 2. Hirai, K. A., Ito, Y., Abe, S., Suzue, T., Irikura, M. I., Mitsuhashi, S.: Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections. Antimicrobial Agents and Chemotherapy 1981, 19: 188–189. 3. Ito, A., Hirai, K., Inoue, M., Koga, H., Suzue, S., Irikura, T., Mitsuhashi, S.: In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrobial Agents and Chemotherapy 1980, 17: 103–108. 4. Khan, M. Y., Siddiqui, Y., Gruninger, R. P.: Comparative in vitro activity of MK-366 and other selected oral antimicrobial agents againstNeisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy 1981, 20: 265–266. 5. Newsom, S. W. B., Matthews, J., Amphlett, M., Warren, R. E.: Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids. Journal of Antimicrobial Chemotherapy 1982, 10: 25–30.
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|